Completed OBSERVATIONAL NCT04639505

Predictive Value of New AMH Test Method for Ovarian Response

Predictive Value of New AMH Test Method for Ovarian Response in Patients With IVF/ICSI

Sponsor: Reproductive & Genetic Hospital of CITIC-Xiangya

Updated 6 times since 2020 Last updated: Jan 11, 2022 Started: Nov 15, 2020 Primary completion: Jun 3, 2021 Completion: Sep 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04639505, this observational or N/A phase trial focuses on AMH and Infertility and remains completed. Sponsored by Reproductive & Genetic Hospital of CITIC-Xiangya, it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Feb 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Mar 2021 — Feb 2022 [monthly]

Recruiting
Jan 2021 — Mar 2021 [monthly]

Recruiting

▶ Show 1 earlier version

Dec 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Nov 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Reproductive & Genetic Hospital of CITIC-Xiangya

Data source: Reproductive & Genetic Hospital of CITIC-Xiangya

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Changsha, China